Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction
- PMID: 18922759
- PMCID: PMC2648899
- DOI: 10.1093/biostatistics/kxn034
Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction
Abstract
Recently, meta-analysis has been widely utilized to combine information across comparative clinical studies for evaluating drug efficacy or safety profile. When dealing with rather rare events, a substantial proportion of studies may not have any events of interest. Conventional methods either exclude such studies or add an arbitrary positive value to each cell of the corresponding 2 x 2 tables in the analysis. In this article, we present a simple, effective procedure to make valid inferences about the parameter of interest with all available data without artificial continuity corrections. We then use the procedure to analyze the data from 48 comparative trials involving rosiglitazone with respect to its possible cardiovascular toxicity.
Figures
Similar articles
-
Meta-analysis of incidence of rare events.Stat Methods Med Res. 2013 Apr;22(2):117-32. doi: 10.1177/0962280211432218. Epub 2012 Jan 4. Stat Methods Med Res. 2013. PMID: 22218366 Review.
-
Analytical issues regarding rosiglitazone meta-analysis.Arch Intern Med. 2011 Jan 24;171(2):179-80; author reply 180. doi: 10.1001/archinternmed.2010.508. Arch Intern Med. 2011. PMID: 21263111 No abstract available.
-
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.Am Heart J. 2008 Jul;156(1):23-30. doi: 10.1016/j.ahj.2008.03.002. Epub 2008 May 5. Am Heart J. 2008. PMID: 18585493 Review.
-
Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.Clin Trials. 2008;5(2):116-20. doi: 10.1177/1740774508090212. Clin Trials. 2008. PMID: 18375649
-
[Rosiglitazone--statistics for benefits and problems].Tidsskr Nor Laegeforen. 2007 Oct 18;127(20):2702-3. Tidsskr Nor Laegeforen. 2007. PMID: 17952157 Norwegian. No abstract available.
Cited by
-
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium.EClinicalMedicine. 2023 Sep 14;64:102212. doi: 10.1016/j.eclinm.2023.102212. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37745025 Free PMC article.
-
The normality assumption on between-study random effects was questionable in a considerable number of Cochrane meta-analyses.BMC Med. 2023 Mar 29;21(1):112. doi: 10.1186/s12916-023-02823-9. BMC Med. 2023. PMID: 36978059 Free PMC article.
-
Bayesian estimation and testing in random-effects meta-analysis of rare binary events allowing for flexible group variability.Stat Med. 2023 May 20;42(11):1699-1721. doi: 10.1002/sim.9695. Epub 2023 Mar 4. Stat Med. 2023. PMID: 36869639 Free PMC article.
-
Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis.Blood Adv. 2023 May 23;7(10):2132-2142. doi: 10.1182/bloodadvances.2022008443. Blood Adv. 2023. PMID: 36053773 Free PMC article.
-
DPYD Genotyping in Patients Who Have Planned Cancer Treatment With Fluoropyrimidines: A Health Technology Assessment.Ont Health Technol Assess Ser. 2021 Aug 12;21(14):1-186. eCollection 2021. Ont Health Technol Assess Ser. 2021. PMID: 34484488 Free PMC article. Review.
References
-
- Bradburn MJ, Deeks JJ, Berlin J, Localio AR. Much ado about nothing: a comparison of the performance of meta-analysis methods with rare events. Statistics in Medicine. 2007;26:53–77. - PubMed
-
- Brown L, Cai T, Dasgupta A. Interval estimation for a binomial proportion. Statistical Science. 2001;16:101–103.
-
- Chan I, Zhang Z. Test-based exact confidence interval for the difference of two binomial proportions. Biometrics. 1999;55:1202–1209. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical